Edition:
United Kingdom

SanBio Co Ltd (4592.T)

4592.T on Tokyo Stock Exchange

2,533JPY
24 Nov 2017
Change (% chg)

¥-232 (-8.39%)
Prev Close
¥2,765
Open
¥2,782
Day's High
¥2,812
Day's Low
¥2,503
Volume
1,368,800
Avg. Vol
431,601
52-wk High
¥2,812
52-wk Low
¥1,012

Chart for

About

SanBio Company Limited is a Japan-based company primarily engaged in the research and development of regenerative cells drugs. The Company has three types of drugs under development, including nerve regeneration cell SB623, used for the treatment of chronic cerebral infarction, traumatic brain injury, age-related macular... (more)

Overall

Beta: --
Market Cap(Mil.): ¥83,119.16
Shares Outstanding(Mil.): 45.42
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 89.23 16.44
EPS (TTM): -- -- --
ROI: -- 2.53 10.62
ROE: -- 3.17 14.20

BRIEF-SanBio signs commitment line agreement worth 1.6 bln yen

* Says it signs a commitment line agreement worth 1.6 billion yen on Aug. 21, with a term from Aug. 21 to July 31, 2021

21 Aug 2017

BRIEF- SanBio receives $20 mln subsidy

* Says it received $20 million subsidy from California Institute for Regenerative Medicine (CIRM), for cerebral infarction phase 2b clinical study

30 Jun 2017

Earnings vs. Estimates